Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22)

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22)

Patients with Myelin Oligodendrocyte Glycoprotein (MOG)-IgG present with isolated optic neuritis or transverse myelitis, acute disseminated encephalomyelitis (ADEM), brainstem or cerebellar features, or cerebral cortical encephalitis. Unlike Multiple Sclerosis (MS) and AQP4-IgG-seropositive Neuromye...

Full description

Bibliographic Details
Main Author:	Samaneh Hosseini
Format:	Article
Language:	English
Published:	Iran University of Medical Sciences 2023-01-01
Series:	Neurology Letters
Subjects:	mogad diagnosis
Online Access:	https://www.neurologyletters.com/article_184227_d41d8cd98f00b204e9800998ecf8427e.pdf

Similar Items

The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children
by: Ünsal Yılmaz
Published: (2024-02-01)

Challenges in the Diagnosis and Management of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
by: Lekha Pandit
Published: (2025-01-01)

A rare presentation of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) as acute hemorrhagic longitudinally extensive transverse myelitis
by: Aniket Nerlekar, et al.
Published: (2023-11-01)

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-04-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series
by: Yohane Gadama, et al.
Published: (2023-10-01)

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD
by: Chaithra Malli, et al.
Published: (2023-05-01)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
by: Osman Corbali, et al.
Published: (2023-02-01)

Characteristics of cerebrospinal fluid oligoclonal band in anti-myelin oligodendrocyte glycoprotein (MOG) antibody associated disease
by: Wenjun Shao, et al.
Published: (2024-03-01)

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
by: Satomi Hiya, et al.
Published: (2023-06-01)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
by: Gina Perez-Giraldo, et al.
Published: (2023-07-01)

A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective
by: Yufei Wang, et al.
Published: (2023-09-01)

Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease in southern China: analysis of 93 cases
by: Xiaojing Li, et al.
Published: (2023-06-01)

Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing
by: Adrian Budhram, et al.
Published: (2024-03-01)

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
by: Angelika Bauer, et al.
Published: (2022-11-01)

Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice
by: Amy E. Wright, et al.
Published: (2024-03-01)

Editorial: MOGAD, current knowledge and future trends
by: Sasitorn Siritho, et al.
Published: (2023-09-01)

Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients
by: Sara I. Taha, et al.
Published: (2025-01-01)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
by: Yajun Yao, et al.
Published: (2022-08-01)

Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)
by: Itay Lotan, et al.
Published: (2023-04-01)

Optic Chiasmitis as an Isolated Manifestation of Myelin Oligodendrocyte Glycoprotein-Associated Disease – a Case Report
by: Nina Barankiewicz-Tyc, et al.
Published: (2024-10-01)

Extensive brainstem lesions in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A case report
by: Yasuyuki Kojita, MD, PhD, et al.
Published: (2024-12-01)

Myelin oligodendrocyte glycoprotein antibody disorder (MOGAD) optic perineuritis following severe COVID19 infection
by: Miguel Leitão, et al.
Published: (2023-12-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
by: Elia Sechi, et al.
Published: (2022-06-01)

MOGAD may not only mimic immune or infectious encephalitis, but can also be triggered by viral infections
by: Josef Finsterer
Published: (2024-08-01)

Neuritis optica bilateral asociado anticuerpos anti-glicoproteina de la mielina del oligodendrocito (MOGAD): Reporte de caso
by: Karelys Moreno Arias, et al.
Published: (2023-12-01)

Neuritis optica bilateral asociado anticuerpos anti-glicoproteina de la mielina del oligodendrocito (MOGAD): Reporte de caso
by: Karelys Moreno Arias, et al.
Published: (2023-12-01)

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers
by: Xin Wang, et al.
Published: (2025-02-01)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
by: Fiona Tea, et al.
Published: (2019-09-01)

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature
by: Yangsa Du, et al.
Published: (2022-11-01)

The Percentage of Neutrophils is Independently Associated with Blood-Brain Barrier(BBB) Disruption in Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD)
by: Cheng X, et al.
Published: (2025-02-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) initially presenting as septic meningoencephalitis in a 16-year-old male
by: Maria Elizabeth Karavassilis, et al.
Published: (2024-06-01)

COVID-19 Vaccine—A Potential Trigger for MOGAD Transverse Myelitis in a Teenager—A Case Report and a Review of the Literature
by: Cristina Oana Mărginean, et al.
Published: (2022-05-01)

Case Report: A Case With MOGAD and Anti-NMDAR Encephalitis Overlapping Syndrome Mimicing Radiological Characteristics of CLIPPERS
by: Jia Guo, et al.
Published: (2022-04-01)

Case Report: MOGAD - a steroid-responsive autoimmune meningoencephalitis mimicking infection
by: Yihui Goh, et al.
Published: (2025-02-01)

High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting
by: Tammy L. Smith, et al.
Published: (2023-07-01)

Myelin oligodendrocyte glycoprotein antibodies in neurological disease
by: Reindl, M, et al.
Published: (2018)

FLAIR hyperintense cortical lesions in anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with seizure following SARS-CoV-2 mRNA vaccination
by: Fumitaka Yoshino, et al.
Published: (2024-03-01)

Criteria for myelin oligodendrocyte glycoprotein antibody‐associated disease: Balancing underdiagnosis with overdiagnosis
by: Er‐Chuang Li, et al.
Published: (2023-08-01)

Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-05-01)

Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD
by: Susanna Asseyer, et al.
Published: (2024-01-01)